Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IgY Lab Systems is a Swedish biotechnology company specializing in the production and purification of polyclonal chicken antibodies, known as Immunoglobulin Y (IgY). Based in the life science hub of Uppsala, the company provides custom antibody services to the global research and diagnostic communities. Their core expertise lies in utilizing the avian immune system to generate antibodies against highly conserved mammalian proteins that are often poorly immunogenic in traditional mammalian hosts like rabbits or mice. IgY Lab Systems offers a comprehensive workflow including antigen design, hen immunization, and proprietary purification methods to extract high-purity antibodies from egg yolks. These avian antibodies provide distinct advantages, such as the lack of cross-reactivity with rheumatoid factors and the human complement system, making them valuable tools in clinical diagnostics and research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IgY Lab Systems.